Expression of a novel class of bacterial Ig-like proteins is required for IncHI plasmid conjugation

PLoS Genet. 2019 Sep 17;15(9):e1008399. doi: 10.1371/journal.pgen.1008399. eCollection 2019 Sep.

Abstract

Antimicrobial resistance (AMR) is currently one of the most important challenges to the treatment of bacterial infections. A critical issue to combat AMR is to restrict its spread. In several instances, bacterial plasmids are involved in the global spread of AMR. Plasmids belonging to the incompatibility group (Inc)HI are widespread in Enterobacteriaceae and most of them express multiple antibiotic resistance determinants. They play a relevant role in the recent spread of colistin resistance. We present in this report novel findings regarding IncHI plasmid conjugation. Conjugative transfer in liquid medium of an IncHI plasmid requires expression of a plasmid-encoded, large-molecular-mass protein that contains an Ig-like domain. The protein, termed RSP, is encoded by a gene (ORF R0009) that maps in the Tra2 region of the IncHI1 R27 plasmid. The RSP protein is exported outside the cell by using the plasmid-encoded type IV secretion system that is also used for its transmission to new cells. Expression of the protein reduces cell motility and enables plasmid conjugation. Flagella are one of the cellular targets of the RSP protein. The RSP protein is required for a high rate of plasmid transfer in both flagellated and nonflagellated Salmonella cells. This effect suggests that RSP interacts with other cellular structures as well as with flagella. These unidentified interactions must facilitate mating pair formation and, hence, facilitate IncHI plasmid conjugation. Due to its location on the outer surfaces of the bacterial cell, targeting the RSP protein could be a means of controlling IncHI plasmid conjugation in natural environments or of combatting infections caused by AMR enterobacteria that harbor IncHI plasmids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / pharmacology
  • Bacteria / genetics
  • Bacterial Proteins / genetics
  • Conjugation, Genetic / genetics*
  • Drug Resistance, Microbial / genetics
  • Immunoglobulin Domains / genetics*
  • Immunoglobulin Domains / physiology
  • Plasmids / genetics
  • R Factors / genetics*
  • Salmonella / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins

Grants and funding

A.P. was the recipient of a FPU fellowship from the Ministerio de Educación, Cultura y Deporte. M.B. was the recipient of a FI Fellowship from the Generalitat de Catalunya. E.G. received a fellowship from the University of Barcelona (APIF). This work was supported by grants CSD2008-00013 from Ministerio de Ciencia y Tecnología, BIO2016-76412-C2-1-R (AEI/FEDER, UE) from Ministerio de Economía, Industria y Competitividad, Fundació La Marató TV3, Spain (Project ref. 201818 10), and CERCA Programme/Generalitat de Catalunya to A.J. and SAF2017-89510-R to A. F. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.